We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
A picture of Laura Elizabeth Lansdowne

Laura Elizabeth Lansdowne profile page

Managing Editor

 at Technology Networks


As managing editor, Laura works with the editorial director to create, inform and maintain the overall editorial strategy for Technology Networks. She oversees the in-house editorial team and works directly with commissioned writers to produce content across the publication’s communities. After obtaining a first-class honors degree in biology, Laura worked as a quality assurance technologist before joining the Wellcome Sanger Institute and undertaking an additional qualification in clinical chemistry. In 2015, she left to pursue pharmaceutical and editorial-based roles, before joining Technology Networks in 2017.


Education


University of Kent  

Nottingham Trent University  

Writtle University College  

Chartered Institute of Editing and Proofreading  


Accreditations


Biology, BSc (Hons) recognised by The University of Kent


Areas of Expertise



Got a Question for Laura Elizabeth Lansdowne?


Get in touch using the contact form linked here and we’ll get back to you shortly.



Published Content
Total: 409
picture of Infographic on a green background
Infographic

Cell‒Cell Communication in Health and Disease

Download this infographic to explore the types of signaling, learn how signals are transmitted and discover techniques for studying cell communication.
An image of Dr. Jay Mandula next to cancer cells and immune cells.
Article

Dr. Jay Mandula Explores the Importance of Diversity in Cancer Research

In this interview, Jay Mandula describes his work in immuno-oncology, the challenges of being transgender in Florida and how increased visibility of LGBTQIA+ scientists can impact STEMM.
Cartoon earth surrounded by leaves, clouds, a lightbulb and a recycle symbol.
Article

Strategies for Sustainable Science at CU Boulder and Beyond

In this interview, Kathryn Ramirez-Aguilar discusses the CU Green Labs Program, her involvement with the International Institute for Sustainable Laboratories and the role of research funders in furthering sustainability within a lab environment.
ARRALYZE glass array with three different shaped wells highlighted. Each well is enlarged to display a different type of cell.
Industry Insight

Navigating the Complexities of Single-Cell Research

The advent of single-cell analysis has marked a transformative era in the life sciences, particularly in the field of drug development. To delve deeper into the subject, Technology Networks spoke with Dr. Nora Fekete-Drimusz, head of biology at ARRALYZE. We discuss the transformative impact of single-cell analysis on life science research and explore how ARRALYZE's multifunctional single-cell platform can support those working in this area.
A futuristic-style illustration of a trophy on a dark blue background.
Industry Insight

SLAS Europe 2024 New Product Award: Top Contenders Announced

Finalists for the New Product Award at the SLAS Europe conference showcase cutting-edge innovations in life sciences, evaluated on technical merit, commercial feasibility, originality, impact and market opportunity. Here, we take a look at the six nominees and the products competing for this year’s award.
A globe with scientists and sustainability-themed symbols and clouds surrounding it.
Article

Redefining Lab Practices To Prioritize Sustainability

Scientists around the world are becoming increasingly conscious of the environmental impact of their research, however, the path to adopting sustainable practices can be complex. This article will discuss how scientists can adjust the way they work to offset the environmental footprint of their labs.
Three women scientists chatting in front of a white board
Article

Laura Eghobamien on Founding the Black Medical and Scientific Network and Advocating for Diversity in STEMM

In 2020, Laura Eghobamien founded the Black Medical and Scientific Network (BMSN), a membership organization dedicated to providing support for minority students and Black professionals in STEMM. Technology Networks recently spoke with Eghobamien to learn more about her motivations for founding the BMSN, her ongoing efforts to enhance diversity in the sciences and the impact she hopes to make in fostering inclusive environments within the STEMM community.
A bin full of plastic laboratory waste
Industry Insight

Keeping Plastic Lab Waste Out of Landfills and Incinerators

Until recently, a lack of specialized services meant there was no definitive method for safely and effectively decontaminating plastic waste for reuse in new consumables. As a result, this waste was incinerated or diverted to landfill. The start-up company LabCycle has tackled this issue head-on, with its innovative approach to laboratory waste management. Technology Networks recently had the pleasure of speaking with LabCycle’s co-founder and chief technology officer Dr. Helen Liang, to learn more about its circular economy for laboratory plastic waste.
A picture of differentiated SH-SY5Y on Revivocell NANOSTACKS™.
Industry Insight

Redefining Preclinical Testing With High-Complexity In Vitro Models

We interview Raffaello Sbordoni, research scientist at Revivocell, to dive deeper into how high-complexity in vitromodels are supporting pharmaceutical development and their future potential.
Ocular Fibrosis, 3D Cell Culture Image, spherical microscopy image with various colors.
Industry Insight

Bridging Academia and Industry: The Evolution of 3D Models in Drug Development

The industry's search for alternatives to traditional preclinical drug testing methods has led to a growing interest in the potential of three-dimensional (3D) in vitro models. To delve deeper into this subject, Technology Networks spoke with Madhu Lal-Nag, chief scientific officer at InSphero, a 3D in vitro model company with a mission to “modernize drug discovery in ways that inspire researchers everywhere to reach their full potential and fuel a new era of breakthrough therapies.”
Advertisement